NAGIOS: RODERIC FUNCIONANDO

Controversies in ameloblastoma management:evaluation of decision making, based on a retrospective analysis

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Controversies in ameloblastoma management:evaluation of decision making, based on a retrospective analysis

dc.contributor.author	Hresko, Andrii	es
dc.contributor.author	Burtyn, Olga	es
dc.contributor.author	Pavlovskiy, Leonid	es
dc.contributor.author	Snisarevskyi, Pavlo	es
dc.contributor.author	Lapshyna, Julia	es
dc.contributor.author	Chepurnyi, Yurii	es
dc.contributor.author	Kopchak, Andrii	es
dc.contributor.author	Karagozoglu, K.H.	es
dc.contributor.author	Forouzanfar, Tymour	es
dc.date.accessioned	2023-06-16T08:36:38Z
dc.date.available	2023-06-16T08:36:38Z
dc.date.issued	2021	es
dc.identifier.citation	Hresko, A., Burtyn, O., Pavlovskiy, L., Snisarevskyi, P., Lapshyna, J., Chepurnyi, Y., Kopchak, A., Karagozoglu, KH., & Forouzanfar, T. (2021). Controversies in ameloblastoma management: evaluation of decision making, based on a retrospective analysis. En Medicina Oral Patología Oral y Cirugia Bucal (pp. e181-e186). Medicina Oral, S.L. https://doi.org/10.4317/medoral.24104	es
dc.identifier.uri	https://hdl.handle.net/10550/88011
dc.description.abstract	The ameloblastoma management is still challenging to the high recurrence rates and significant morbidity associated with radical treatment. The purpose of this 10-year retrospective study was to analyze the influence of ameloblastoma type and treatment strategy on the long-term outcomes and recurrence rates. The retrospective analyses of 64 histologically-confirmed ameloblastoma cases was performed. The possible risk factors for recurrence and the development of complications were estimated statistically. The treatment strategy applied for this group of patients was the following: thirty-four patients (53.1%) were treated conservatively with enucleation or extended bone curettage. Radical treatment (bone resection) was applied in 30 (46.9%) cases. The follow-up period ranged from 2 to 10 years (mean value 4.28 ± 3,26). General recurrence rate consisted 32.8%. This study did not find significant correlations between clinical or histopathological features of the ameloblastoma and the recurrence rate. The only factor that significantly influence recurrence rate was the treatment strategy (41% in conservative treatment vs 15% in radical treatment, p<0.05). Postoperative complications were observed in 42 patients (65.6%) and included face asymmetry and disfigurement (17.2%), temporary paresthesia of the inferior alveolar nerve (IAN) - 23.4%, permanent paresthesia of IAN - 20.3%, paresis of a marginal branch of the facial nerve - 6.3%, infection 12.5%, and swelling - 20.3%. The complication rates, esthetic and functional deficiency were significantly higher in radically treated patients (p<0.05) Our study confirms that higher recurrence rate is associated with conservative treatment for ameloblastoma, while radical treatment leads to an increased number of postoperative complications that affect the patient's quality of life.	es
dc.subject	insertion torque	es
dc.subject	rfa	es
dc.subject	undersized drilling	es
dc.subject	immediate implants	es
dc.subject	primary stability	es
dc.subject	secondary stability	es
dc.title	Controversies in ameloblastoma management:evaluation of decision making, based on a retrospective analysis	es
dc.type	journal article	es_ES
dc.subject.unesco	UNESCO:CIENCIAS MÉDICAS	es
dc.identifier.doi	10.4317/medoral.24104	es
dc.type.hasVersion	VoR	es_ES
dc.identifier.url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980285/